Shanghai Kaibao Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Kaibao Pharmaceutical Company Limited with three other
companies in this sector in China:
Guangxi Wuzhou Zhongheng Group, Ltd.
sales of 1.34 billion Chinese Renmimbi [US$198.22 million]
of which 91%
was Pharmaceutical Segment),
Guilin Sanjin Pharmaceutical Co Ltd
(1.37 billion Chinese Renmimbi [US$202.72 million]
of which 96%
was Proprietary Chinese medicine), and
Xiangxue Pharmaceutical Co Ltd
(1.46 billion Chinese Renmimbi [US$216.29 million]
of which 53%
was Pharmaceutical Manufacturing).
During the year ended December of 2015, sales at
Shanghai Kaibao Pharmaceutical Company Limited were 1.40 billion Chinese Renmimbi (US$206.24 million).
decrease of 5.8%
versus 2014, when the company's sales were 1.48 billion Chinese Renmimbi.